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Abstract
Snail family proteins are core EMT (epithelial-mesenchymal transition) regulatory factors that play essential roles in both
development and disease processes and have been associated with metastasis in carcinomas. Snail factors are required for
the formation of neural crest stem cells in most vertebrate embryos, as well as for the migratory invasive behavior of these
cells. Snail factors have recently been linked to the formation of cancer stem cells, and expression of Snail proteins may be
associated with tumor recurrence and resistance to chemotherapy and radiotherapy. We report that Co(III)-Ebox is a potent
inhibitor of Snail- mediated transcriptional repression in breast cancer cells and in the neural crest of Xenopus. We further
show that the activity of Co(III)-Ebox can be modulated by temperature, increasing the utility of this conjugate as a Snail
inhibitor in model organisms. We exploit this feature to further delineate the requirements for Snail function during neural
crest development, showing that in addition to the roles that Snail factors play in neural crest precursor formation and
neural crest EMT/migration, inhibition of Snail function after the onset of neural crest migration leads to a loss of neural
crest derived melanocytes. Co(III)-Ebox-mediated inhibition therefore provides a powerful tool for analysing the function of
these core EMT factors with unparalleled temporal resolution. Moreover, the potency of Co(III)-Ebox as a Snail inhibitor in
breast cancer cells suggests its potential as a therapeutic inhibitor of tumor progression and metastasis.
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Introduction
Snail family transcription factors, consisting of Snai1 (also
known as Snail) Snai2, and Snai3 (also known as Slug and SMUC
respectively), are a family of zinc finger transcriptional repressors
that are key regulators of epithelial-mesenchymal transitions
(EMTs) during embryonic development, and of metastasis in
epithelial-derived carcinomas. The plastic interconversion of
epithelial cells to mesenchymal cells allows cellular remodelling
during wound healing, tissue regeneration in differentiated tissues
in the adult, [1,2,3,4] and is essential for numerous developmental
processes, including gastrulation, neural crest cell migration,
palatal fusion, and mammary branching morphogenesis
[5,6,7,8]. In Xenopus, Snai2 and Snai1 are among the earliest
factors expressed in response to neural crest inducing signals. They
play essential roles in both the establishment of the multipotent
precursor population and for the subsequent EMT/migration of
definitive neural crest cells [7,9]_ENREF_9. Neural crest cells
have emerged as an excellent model system for understanding the
function and regulation of Snail proteins in both normal and
pathological contexts.
Snail proteins, together with other core EMT/neural crest
regulatory factors, are implicated in epithelial plasticity and EMT-
like processes during tumor progression [10,11]. Snai1 expression,
and features of EMT have been observed in breast, prostate, lung,
ovarian, melanoma, colon and esophageal cancers
[12,13,14,15,16,17,18]. Introduction of Snail factors into epithelial
tumors results in cells that can disseminate from the primary
tumor, are resistant to apoptosis, radiotherapy and chemotherapy,
evade immune recognition, and exhibit markers of stem cells
[19,20,21,22]. Mechanistically, Snail proteins repress the expres-
sion of E-cadherin and components of adherens junctions, and
Snail expression has been shown to correlate with tumor
malignancy [17,23,24].
Snail factors are attractive targets for the development of
pharmaceutical agents. Blocking Snail protein function has the
potential to prevent tumor cell metastasis by interfering with
processes such as EMT, cytoskeletal remodelling, cell migration
and invasion. Moreover, the recent link between Snail and cancer
stem cells [19,25,26] suggests that inhibitory agents could prove to
be potent inhibitors of tumor recurrence. In addition to their
potential as anti-cancer therapeutics, inhibitors of Snail function
would be powerful tools that could facilitate the study of these
transcriptional regulatory factors in model cell types such as the
neural crest, and in other developmental processes.
Co(III) Schiff base complexes can be used as selective inhibitors
of transcription factors and enzymes through a rational design of
the conjugated oligonucletide or peptide (Figure 1A)
[27,28,29,30]. Here, we report that a Co(III)-DNA conjugate,
Co(III)-Ebox, is a potent inhibitor of Snail-mediated repression
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in breast cancer cells. In breast cancer cells, Co(III)-Ebox
selectively inhibits Snail-mediated repression of the E-cadherin
promoter in a dose dependent manner. Xenopus embryos treated
with this agent display defects in the induction and/or migration of
neural crest cells, depending upon the timing of administration.
We find that inhibitory effects of this compound can be modulated
with temperature, and we exploit this feature to further investigate
the temporal requirements for Snail family factors in the neural
crest.
Here, we show that the inhibition of Snail function after the
onset of neural crest migration leads to a loss of neural crest
derived melanocytes, further highlighting the multiple essential
roles that Snail proteins play in the development of neural crest
cells. The temporal control of Snail function afforded by Co(III)-
Ebox provides a powerful new tool for dissecting the role these
proteins play in cellular and developmental processes with
unprecedented temporal resolution. The robust and specific
inhibition of Snail function by Co(III)-Ebox in breast cancer cells
suggests that this reagent holds considerable therapeutic potential
as an inhibitor of tumor progression and metastasis.
Results
Inhibition of Snail DNA-binding and transcriptional
repression in breast cancer cells
We examined the ability of Co(III)-Ebox to selectively block
Snail-mediated transcriptional repression in tumor-derived cells.
In initial experiments we exploited the fact that MCF7 breast
cancer cells lack endogenous nuclear Snai1 (Figure S1) and that
introduction of Snai1 into these cells has been shown to repress E-
cadherin luciferase reporter activity (Figure S2) [31], allowing for a
clear link between the effects of the agent and the presence of its
target. The effects of treatment with Co(III)-Ebox were compared
to control treatment with vehicle, Co(III)-sb, Ebox oligonucleotide
or Co(III)-EboxMut (Figure 1A). Co(III)-sb and Ebox were used to
assess the effects of the Co(III) Schiff base or the Ebox
oligonucleotide individually. Co(III)-EboxMut is a form of the
conjugate in which the Ebox sequence has been mutated to
diminish Snail protein binding, and was used to further evaluate
the specificity of the binding interaction (Figure 1A, Figure S3).
MCF7 cells transfected with murine Snai1 (MSnail) and the
luciferase reporter show a dose-dependent increase in E-cadherin
Figure 1. Co(III)-Ebox alleviates murine Snai1-mediated E-cadherin promoter repression. (A) Chemical structures; Co(III) Schiff base
complex, Co(III)-sb; Ebox duplex oligonucleotide, Ebox; Co(III)-DNA conjugate with 2-base pair substitution in the Ebox region; Co(III)-EboxMut; Co(III)-
DNA conjugate targeted to Snail factors, Co(III)-Ebox. (B) E-cadherin reporter gene activity in MCF7 cells expressing MSnail treated with Co(III)-Ebox
from 0 to 15 nM. Data are represented as means 6 s.e.m., n=4. T-tests determined statistical significance from controls of 10 nM (P=0.0034),
12.5 nM (P=0.0060) and 15 nM (P=0.0109) (*). (C) E-cadherin reporter gene activity in MCF7 cells expressing MSnail treated with 15 nM Co(III)-sb,
Ebox, Co(III)-EboxMut or Co(III)-Ebox. Data are represented as means 6 s.e.m., n=4. T-tests determined statistical significance from controls of Co(III)-
EboxMut (P=0.0214) and Co(III)-Ebox (P=0.0035) (*). Co(III)-Ebox to be significantly different from Co(III)-EboxMut (P=0.0008) (**). (D) E-cadherin
reporter gene activity in MCF7 cells transfected with pCS2+ (vector) treated with 15 nM Co(III)-sb, Ebox, Co(III)-EboxMut or Co(III)-Ebox. Data are
represented as means 6 s.e.m., n=4. T-tests determined no statistical significance between the means. (E) MCF7 cell viability after treatment with
Co(III)-Ebox at indicated concentrations after 24 h. Data are represented as means 6 s.e.m., n=3. T-tests determined no statistical significance
between the means.
doi:10.1371/journal.pone.0032318.g001
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icant changes in reporter gene activity were observed with 10 nM
Co(III)-Ebox (P=0.0034). Maximal effects were achieved by
treatment with 15 nM Co(III)-Ebox (P=0.0109, Figure 1B).
Administration of Co(III)-Ebox significantly increased E-cadherin
reporter activity while controls Co(III)-sb, Ebox or, Co(III)-
EboxMut had reduced effects (1.760.21 fold compared to
3.360.35 fold change relative to vector control P=0.0008)
(Figure 1C). Off-target effects due to reaction of the compound
with proteins from other pathways appear to make no significant
contribution to the changes in luciferase activity, as the change in
E-cadherin promoter activity was dependent on the presence of
transfected MSnail. These data provide strong evidence that the
effects of Co(III)-Ebox on E-cadherin repression are a consequence
of its ability to inactivate Snail.
We previously demonstrated that Co(III)-Ebox selectively
targets Ebox-binding zinc finger transcription factors [27]. In that
study we found that Co(III)-Ebox does not inhibit either Ebox-
binding transcription factors that lack zinc finger domains, or zinc
finger containing proteins that do not bind Ebox consensus
sequences [27]. These dual requirements are due to the two-part
targeting mechanism utilized by Co(III)-Ebox. Proteins are first
selectively targeted via their ability to bind the Ebox-containing
oligonucleotide, and then irreversibly inactivated through interac-
tion of the Co(III) Schiff base complex with histidine residues in
the zinc finger region [27]. Consequently, the Ebox binding
bHLH transcription factor MitF fails to be inhibited by
concentrations of Co(III)-Ebox 100 fold higher than those that
inhibit XSnai2 (Figure S4). Furthermore, treatment of MCF7 cells
with Co(III)-Ebox had no impact on cell viability at the
concentrations utilized for Snail inhibition (Figure 1E). No
significant changes in viability were observed following treatment
with concentrations of Co(III)-Ebox up to 60 nM (4 fold the
working concentration).
Experiments in MCF7 cells demonstrated the ability of the
Co(III)-Ebox conjugate to inhibit exogenously provided Snail
protein. We next wished to evaluate the effectiveness of Co(III)-
Ebox in blocking the function of endogenous Snail proteins.
MDA-MB-231 cells are metastatic breast cancer cells that express
multiple zinc finger transcriptional repressors, including Snai1
(Figure S1), Snai2, Zeb1 and Zeb2, all of which can bind Eboxes in
the E-cadherin promoter and regulate EMT [32,33,34]. We have
shown that DNA binding by Snai1, Snai2 and Zeb2 is inhibited by
Co(III)-Ebox in vitro [27]. MDA-MB-231 cells therefore make an
excellent model in which to assess ability of Co(III)-Ebox to
inactivate the function of multiple distinct endogenous targets and
alleviate the transcriptional repression of the E-cadherin promoter
observed in these cells. We found that treatment of MDA-MB-231
cells expressing an E-cadherin reporter with Co(III)-Ebox led to a
significant increase in promoter activity, with the greatest effects
achieved at a dose of 40 nM Co(III)-Ebox (fold change 3.460.7,
Figure 2A). No significant changes in E-cadherin promoter activity
were noted following treatment with Co(III)-sb, or Ebox alone. As
observed in MCF7 cells, the activity of Co(III)-EboxMut was
significantly diminished compared to Co(III)-Ebox (P=0.0021,
Figure 2B). In previous studies, potential E-box independent
effects on E-cadherin promoter regulation have been assessed using
a control reporter in which two base-pair substitutions have been
introduced into each of the three Eboxes (EcadMut-luc) resulting
in decreased ability of Snai1, Snai2, Zeb1 and Zeb2 to bind these
sites (Figure S5) [35]. Consistent with the observed effects on E-
cadherin promoter activity being a consequence of regulation by
endogenous E-box binding transcription factors, treatment with
Co(III)-Ebox, (or controls Ebox, Co(III)-EboxMut or Co(III)-
Ebox) had no effect on EcadMut promoter activity (Figure 2C).
Cell viability was unaffected by treatment with Co(III)-Ebox
(Figure 2D). No significant changes in cell viability were observed
up to 60 nM, approximately double the concentration used in
these studies.
To confirm that the effects of Co(III)-Ebox on E-cadherin
promoter activity are a consequence of its ability to interfere with
Snai1 DNA binding, we performed EMSAs on lysates from MDA-
MB-231 cells that had been treated with Co(III)-Ebox for 24 h
(Figure 2E). Treatment of MDA-MB-231 cells with 35 or 40 nM
Co(III)-Ebox led to a significant reduction of DNA binding by
endogenous Snai1, resulting in a reduction to 55.0% of the vector
control at 35 nM and 25.4% at 40 nM Co(III)-Ebox, both of
which are significantly different from the vector control (P=0.025
for 35 nM and P=0.0013 for 40 nM, Figure 2G). Although
Co(III)-Ebox reduces Snai1 DNA binding, it does not alter total
Snai1 protein levels (Figure 2E, Figure S6). Reduction of Snail
DNA-binding in MDA-MB-231 cells was also achieved using a
shRNA targeting Snai1 (Fig. 2F). In this case, however, the
decrease in DNA binding correlated with decreased Snail protein
expression, confirming the distinct mechanisms employed by these
two inhibitory agents (Fig. 2F).
Neural crest formation is inhibited by Co(III)-Ebox in a
temperature- dependent matter
Neural crest cells have proven to be a powerful in vivo model for
investigating the role of Snail proteins in EMT and invasive cell
behaviour, as well as the regulatory mechanisms that control the
function of Snail factors in numerous developmental and
pathological processes [36,37]. We therefore examined the efficacy
of Co(III)-Ebox for inhibiting Snail function during neural crest
development in Xenopus embryos. This system provides an
excellent in vivo model for determining the effectiveness of the
Co(III)-Ebox conjugate when administered to complex tissues. In
Xenopus, both Snai1 and Snai2 are expressed in pre-migratory
neural crest precursor cells and contribute to the stem cell like
properties of these cells [4,7]. Loss of Snail function leads to loss of
Figure 2. Co(III)-Ebox binds target proteins to alleviate transcriptional repression in metastatic MDA-MB-231 cells. (A) E-cadherin
reporter gene activity in MDA-MB-231 cells treated with Co(III)-Ebox from 0 to 40 nM. Data are represented as means 6 s.e.m., n=4. T-tests
determined statistical significance from controls of 40 nM (P=0.0489) (*). (B) E-cadherin reporter gene activity in MDA-MB-231 cells treated with
35 nM Co(III)-sb, Ebox, Co(III)-EboxMut or Co(III)-Ebox. Data are represented as means 6 s.e.m., n=4. T-tests determined statistical significance from
controls of Co(III)-EboxMut (P=0.0290) and Co(III)-Ebox (P=0.0001) (*). Co(III)-Ebox to be significantly different from Co(III)-EboxMut (P=0.0008) (**).
(C) Luciferase reporter gene activity in MDA-MB-231 cells with EcadMut-luc reporter treated with 35 nM Co(III)-sb, Ebox, Co(III)-EboxMut or Co(III)-
Ebox. Data are represented as means 6 s.e.m., n=4. T-tests determined no statistical significance between the means. (D) MDA-MB-231 cell viability
after treatment with Co(III)-Ebox at indicated concentrations after 24 h. Data are represented as means 6 s.e.m., n=3. T-tests determined no
statistical significance between the means. (E) Inhibition of Snail DNA binding in MDA-MB-231 cells after 24 h with 0 to 40 nM Co(III)-Ebox. A
representative EMSA of triplicate samples is shown with Western blots of Snai1 and Actin. (F) A representative EMSA of MDA-MB-231 cells treated
with shRNA targeting Snai1 with Western blots of Snai1 and Actin. (G) Quantification of the percentage of Slug probe bound to Snai1 in (E) by using a
STORM 680 phosphoimager. Data are represented as the means 6 s.e.m., n=3.
doi:10.1371/journal.pone.0032318.g002
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In situ hybridization of Sox10 expression showing neural crest formation (left) and Twist expression showing neural crest migration (right) of embryos
injected with Co(III)-Ebox into one cells of embryos at the 8-cell stage. Embryos were co-injected with b-galactosidase mRNA as a lineage tracer (red
staining). Neural crest forming/migrating regions indicated with arrowheads on the injected side. (B, C) In situ hybridization showing the neural crest
of control embryos or embryos injected with Co(III)-sb, Ebox, Co(III)-EboxMut or Co(III)-Ebox and grown at 14uC (B) or 27uC (C). Top panel: whole
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ability of Co(III)-Ebox to inhibit Snai1/2 function in vivo.
To assess the consequence of Co(III)-Ebox on neural crest cell
formation and migration, Co(III)-Ebox was injected, along with b-
galactosidase mRNA as a lineage tracer, into single cells of eight-
cell stage embryos. When injected embryos were examined by in
situ hybridization at neurula stages, we found that Sox10 expression
was consistently diminished on the Co(III)-Ebox-injected side of
the embryo (Figure 3A). At stages when neural crest cells have
commenced migration, we found that cells on the Co(III)-Ebox
injected side did not migrate to the same extent as those cells on
the uninjected control side as visualized by Twist expression
(Figure 3A). Importantly, however, we sometimes observed defects
in neural crest cell formation/migration on the side of the embryos
contra-lateral to the injection site, which is not observed following
injection with cell autonomous agents such as mRNA.
Because of the early administration of Co(III)-Ebox in these
experiments, the defects observed in neural crest cell migration
could be a secondary consequence of depleting the neural crest cell
population. Moreover, if Co(III)-Ebox can function non-cell
autonomously and cross the midline, it could also inhibit Snail
function in the mesoderm in addition to the neural crest. We
therefore sought to identify protocols for administering Co(III)-
Ebox that would allow greater spatial and temporal control over its
activity.
To inhibit Snail at a developmental time more proximal to the
formation of neural crest precursor cells, Co(III)-sb, Ebox, Co(III)-
Ebox or Co(III)-EboxMut were introduced into the blastocoel of
developing Xenopus embryos during late gastrula stages, when the
process of neural crest induction is underway. Introduction of the
inhibitory agent at this stage would avoid effects on Snail protein
function in the mesoderm during earlier (blastula and early
gastrula) stages. Injected embryos were cultured to neurula stages
(stage 18/19), and the formation of neural crest precursor cells was
evaluated using in situ hybridization for FoxD3 and Sox10,
expression of which marks the neural crest precursor population
at these stages. In wildtype embryos, neural crest precursor cells
border the neural plate/prospective CNS (see cartoon in
Figure 3D). Embryos were simultaneously probed for expression
of Krox20, which is expressed in two stripes of cells in the hindbrain
CNS (pale blue cells marked by blue arrow in the Figure 3D).
Hindbrain expression of Krox20 is not dependent on Snai1/2
function, and therefore this gene serves as a normalization control.
In addition, because some of our preliminary experiments had
suggested that the ability of Co(III)-Ebox to inhibit target proteins
might be at least partially temperature dependent, we examined
FoxD3 and Sox10 expression in embryos that had been reared at
either 14uCo r2 7 uC following treatment with experimental or
control compounds.
We found that when embryos were cultured at 14uC, they
displayed normal expression of FoxD3 or Sox10 following treatment
with either Co(III)-Ebox or control compounds (Figure 3B, Figure
S7). By contrast, when embryos treated with Co(III)-Ebox were
reared at 27uC, expression of both FoxD3 and Sox10 was
substantially diminished, whereas expression of Krox20 remained
unchanged (Figure 3C, Figure S7). Importantly, treatment of
embryos with Co(III)-sb, Ebox, or Co(III)-EboxMut had no effect
on the expression of FoxD3 or Sox10 (Figure 3C, Figure S7).
Together these findings indicate that Co(III)-Ebox inhibits Snail-
dependent neural crest precursor formation in a temperature
dependent manner.
For the Co(III)-Ebox conjugate to be of most utility as an
experimental or therapeutic inhibitor of Snail protein function, it
must be stable and retain its inhibitory activity over time. In order
to examine the stability of Co(III)-Ebox with respect to its Snail
inhibitory activity, cell lysates prepared from Xenopus embryos were
treated with the compound. At designated time points, the
continued ability of Co(III)-Ebox to inhibit Snail protein function
was assayed by introducing a defined amount of in vitro translated
XSnai2 protein to the Co(III)-Ebox treated embryo lysates.
Following incubation in the conjugate-treated lysates, the DNA
binding ability of the Snail protein was evaluated by EMSA. We
found that the Co(III)-Ebox conjugate remained stable and active
in the cellular lysates for at least 24 hours, as over this time period
it retained the ability to efficiently inhibit DNA binding by XSnai2
(Figure 3F).
Temperature-dependent inhibition of neural crest cell
migration by Co(III)-Ebox inhibition of Snail
In addition to the essential role that Snail family transcription
factors play in the formation of the neural crest stem cell
population, they are also required later in neural crest cell
development for the onset of migration. This role is linked to the
ability of Snail proteins to mediate EMT and downregulate cell
adhesion molecules such as E-cadherin, leading to delamination of
neural crest cells from the neuroepithelium [38]. In order to
determine if Co(III)-Ebox could specifically inhibit the effects of
Snail on cell behavior, bypassing effects on the precursor cell
population, Co(III)-Ebox or Co(III)-EboxMut was introduced into
the archenteron at neurula stages (stage 13), after neural crest
precursor cells had already formed. To ensure that treatment at
these stages did not affect the precursor population, treated
embryos were cultured at the restrictive (14 uC) or permissive (27 u)
temperature to stage 18/19 (late premigratory stages) and
examined by in situ hybridization for expression of FoxD3 or
Sox10. Expression of both of these genes was unchanged (Figure
S8), indicating that the maintenance of the neural crest cell
population was not impaired by Co(III)-Ebox or Co(III)-EboxMut
mount in situ hybridization showing FoxD3 expression in the neural crest and Krox20 expression in rhombomeres 3/5 of the CNS. For FoxD3 embryos
reared at 14uC, Co(III)-sb n=12; Ebox n=16; Co(III)-EboxMut n=16; and Co(III)-Ebox n=13. For FoxD3 embryos reared at 27uC, Co(III)-sb=13; Ebox
n=18; Co(III)-EboxMut n=14; and Co(III)-Ebox n=18. Bottom panel: expression of Sox10 in the neural crest and Krox20 (blue arrowheads). For Sox10
embryos reared at 14uC, Co(III)-sb n=21; Ebox n=33; Co(III)-EboxMut n=35; and Co(III)-Ebox n=38. For Sox10 embryos reared at 27uC, Co(III)-sb=33;
Ebox n=35; Co(III)-EboxMut n=35; and Co(III)-Ebox n=36. Loss of Sox10 and FoxD3 is seen in the neural crest forming regions of embryos treated
with Co(III)-Ebox grown at 27uC (red arrowheads). (D) Cartoon representation of expected in situ hybridization result for Krox20 and neural crest
markers (Sox10 and FoxD3) at stage 17. Black staining represents neural crest forming regions visualized by in situ hybridization for Sox10 or FoxD3
and indicated by red arrows. Pale blue staining indicates hindbrain forming regions of rhombomeres 3 and 5 visualized by in situ hybridization with
Krox20 and indicated by blue arrows. (E) Cartoon representation of expected in situ hybridization result for Krox20 and neural crest markers (Sox10 and
Twist) during neural crest cell migration. Black staining represents migrating neural crest regions visualized by in situ hybridization for Sox10 or Twist
and indicated by red arrows. Pale blue staining indicates hindbrain forming regions of rhombomeres 3 and 5 visualized by in situ hybridization with
Krox20 and indicated by blue arrows. (F) Co(III)-Ebox incubated in embryo lysate for 0 to 24 hours retains the and ability to inhibit XSnai2 DNA
binding as visualized by EMSA.
doi:10.1371/journal.pone.0032318.g003
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PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e32318Figure 4. Co(III)-Ebox impairs neural crest cell migration in Xenopus embryos independently of neural crest specification. (A–D) In situ
hybridization showing neural crest of embryos injected with Co(III)-Ebox or Co(III)-EboxMut during neurulation stages maintained at 14uC (A, C) or
27uC (B, D). (A, B) Co(III)-Ebox does not affect pre-migratory neural crest at 14uC (A) or 27uC (B) seen by in situ hybridization for FoxD3 (top panel) or
Sox10 (bottom panel) For FoxD3 embryos maintained at 14uC, untreated n=14; Co(III)-EboxMut n=15; and Co(III)-Ebox n=15. For embryos
maintained at 27uC, untreated=15; Co(III)-EboxMut n=15; and Co(III)-Ebox n=15. For Sox10 embryos maintained at 14uC, untreated n=12; Co(III)-
EboxMut n=15; and Co(III)-Ebox n=15. For embryos maintained at 27uC, untreated=15; Co(III)-EboxMut n=15; and Co(III)-Ebox n=15. Krox20 is
used to visualize non neural crest tissue in the hindbrain. (C) Embryos treated with Co(III)-Ebox have normal neural crest migration at 14uC. (D)
Embryos treated with Co(III)-Ebox grown at 27uC show impaired neural crest migration (red arrowheads) visualized by in situ hybridization for Twist
and Krox20 (top panel) or Sox10 and Krox20 (bottom panel). For Twist embryos maintained at 14uC, untreated n=14; Co(III)-EboxMut n=14; and
Co(III)-Ebox n=14. For embryos maintained at 27uC, untreated n=11; Co(III)-EboxMut n=10; and Co(III)-Ebox n=17. For Sox10 embryos maintained
at 14uC, untreated n=14; Co(III)-EboxMut n=11; and Co(III)-Ebox n=12. For embryos maintained at 27uC, untreated n=13; Co(III)-EboxMut n=12;
and Co(III)-Ebox n=14. (E, F) Quantification of normalized neural crest migration from Twist expression represented as means 6 s.e.m.
M=mandibular, H=hyoid, BA=anterior branchial, BP=posterior branchial. (E) T-tests determined no significant difference between embryos at 14uC.
(F) T-tests determined that neural crest streams of embryos treated with Co(III)-Ebox are significantly different from controls [single star (*), M,
P=0.0002; H, P,0.0001; BA, P,0.0001 and BP, P,0.0001] and from embryos treated with Co(III)-EboxMut [double stars (**)] M, P=0.0245; H,
P=0.0004, BA, P=0.0005; and BP, P=0.0001] at 27uC.
doi:10.1371/journal.pone.0032318.g004
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results provide novel temporal insights into the requirements for
Snail protein function during neural crest precursor formation,
strongly suggesting that after their essential role in the initial
establishment of the precursor population, Snail function is
dispensable at least until the onset of neural crest migration.
To examine if Co(III)-Ebox disrupts neural crest cell migration
when administered after neural crest precursor cells have formed,
embryos treated with Co(III)-EboxMut or Co(III)-Ebox were
allowed to develop to stage 25–28 when the cranial neural crest
has migrated ventrally to the pharyngeal pouches. Neural crest cell
migration was unimpaired in Co(III)-Ebox treated embryos and
control embryos reared at 14 uC as assessed by the distances
migrated by Twist and Sox10 expressing neural crest cells
(Figure 4C, cartoon in Figure 3E depicts normal pattern of neural
crest migration marked by red arrows). Krox20 expression in
rhombomeres 3/5 of the hindbrain and in migratory neural crest
cells was also normal (Figure 4C). Quantification of distance
migrated by Twist expressing cells revealed no significant
differences between untreated embryos or those treated with
Co(III) or Co(III)-EboxMut (Figure 4E).
In marked contrast to embryos reared at 14 uC, when Co(III)-
Ebox treated embryos were reared at 27 uC they displayed
significant defects in neural crest migration. These embryos
showed a decrease in distance migrated by all neural crest streams
(mandibular, hyoid, anterior and posterior branchial) as compared
to uninjected control embryos or Co(III)-EboxMut injected
embryos, as assessed by Twist, Sox10 or Krox20 expression
(Figure 4D). Krox20 expression in the hindbrain was unimpaired
in these experiments; expression in all treated embryos was
indistinguishable from untreated embryos (Figure 4D). Similarly,
embryos injected with Co(III)-EboxMut displayed normal neural
crest cell migration as compared to uninjected control embryos.
Quantification of the distance migrated by Twist expressing neural
crest cells showed that embryos injected with Co(III)-Ebox
displayed an up to 87% decrease in migration distance when
cultured at 27uC (Figure 4F). All streams of neural crest cells
showed significant deficits in migration compared to control
embryos, or embryos treated with Co(III)-EboxMut. In embryos
treated with Co(III)-EboxMut, neural crest migration was
indistinguishable from that in control embryos (Figure 4F).
Co(III)-Ebox prevents the formation of the neural crest
derived melanocytes
Our findings demonstrate that Co(III)-Ebox can be used to
distinguish temporally distinct requirements for Snail protein
function during neural crest precursor formation and neural crest
migration. We next sought to determine if we could use this
inhibitor to identify additional, later, requirements for Snail
proteins during neural crest cell fate diversification. For these
experiments, Co(III)-Ebox or Co(III)-EboxMut was introduced
into the archenteron at neurula stages (stage 13, as in Figure 4),
and embryos were reared to neural crest migratory stages at 14uC.
Under these conditions neural crest cell migration proceeded
normally, as evidenced by unperturbed patterns of Twist and
Krox20 expression in migratory neural crest cells (Figure 5A).
Quantification of the distance migrated by Twist expressing neural
crest cells showed no significant differences regardless of treatment
(Figure 5B). Once neural crest cell migration was underway,
treated embryos were either maintained at 14uC or shifted to
27uC, and then cultured to stages when effects on neural crest cell
fate diversification could be evaluated. Following normal neural
crest cell migration along specific embryonic pathways, these cells
differentiate into a diverse array of derivatives that includes
neurons and glial cells of the peripheral nervous system,
melanocytes, smooth muscle cells, connective tissue and cranio-
facial cartilage [39]. We therefore asked if Co(III)-Ebox-mediated
Snail inhibition would interfere with the ability of neural crest cells
to adopt any of these fates. Notably, we observed striking deficits in
melanocyte formation in embryos that were treated with Co(III)-
Ebox and reared at 27uC. By contrast, embryos treated with
Co(III)-EboxMut exhibited normal numbers and patterns of
melanocytes. Similarly, melanocyte formation was normal in
embryos treated with Co(III)-Ebox or Co(III)-EboxMut and
cultured at 14u C (Figure 5C, Figure S9).
The inhibition of melanocyte formation noted following Co(III)-
Ebox-mediated Snail inhibition were in contrast for what we
observed when we examined neural crest derived cranial cartilage,
neurons, and glial cells. We found that craniofacial cartilage
formation was normal in all treated embryos at both 14u C and
27u C (Figure 5D, Figure S9). Similarly, the formation of PNS
neurons and glia in the cranial ganglia, as visualized by N-tubulin
and FoxD3 expression respectively, was unperturbed at stage 28
following Co(III)-Ebox-mediated Snail inhibition, or with control
treatment (Figure 5E and 5F, Figure S9). These data suggest that
in addition to playing required roles in the formation of neural
crest precursor cells, and in the EMT/migratory behaviour of
these cells, Snail plays a subsequent role in the formation of neural
crest derived melanocytes. Our data also suggests that additional
Snail function may not be required for the formation of cartilage,
cranial neurons and glia, although it remains possible that the
delivered dose was sufficient to block Snail function in melanocyte
precursors but not in the precursors of neural crest derived
cartilage, neurons and glia. The results in melanocytes, however,
further highlight the utility of the Co(III)-Ebox conjugate as a
potent chemical inhibitor of Snail family function that can be
administered with high temporal resolution. The stability, potency,
and temperature dependence of this agent make it a powerful tool
for studying a family of transcriptional regulatory proteins that
play multiple essential roles in embryonic development and are
core mediators of both developmental and pathological EMTs.
Our findings further suggest that this agent may hold therapeutic
promise as an inhibitor of tumor metastasis.
Discussion
Snail family zinc finger transcriptional repressors are essential
for the formation of the neural crest stem cells, and are also
required later in neural crest development for the onset of invasive
and migratory behaviour. The proliferative, anti-apoptotic,
migratory, and invasive properties that Snail factors confer on
neural crest cells are recapitulated when Snai1 and Snai2 and other
core regulators of EMT, including Zeb1 and Zeb2, are expressed in
epithelial tumor cells. The Snail protein family is highly studied for
these reasons, and inhibitors of Snail function are therefore of high
potential impact and importance for both basic science and
clinical applications.
We have shown Snail factors can be potently inhibited by
Co(III)-Ebox in vitro and in vivo. Inhibiting DNA binding by Snail
proteins alleviates Snail-mediated transcriptional repression. The
effects of Co(III)-Ebox are highly selective, as sequence specific
controls with two base substitutions have greatly diminished effects
on Snail function, strong evidence that off-target effects are
limited. In vitro data further confirms that Co(III)-Ebox does not
inhibit other Ebox-binding proteins that do not contain zinc finger
domains, including MitF. Together these data strongly substan-
tiate the specificity of Co(III)-Ebox for Ebox-binding zinc finger
transcription factors, and indicate that there are at most nominal
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PLoS ONE | www.plosone.org 8 February 2012 | Volume 7 | Issue 2 | e32318Figure 5. Temperature modulation of Co(III)-Ebox-mediated Snail inhibition reveals a requirement for Snail in melanocyte
formation. Neurula stage embryos injected with Co(III)-Ebox or Co(III)-EboxMut in the archenteron space were maintained at 14uC and (A) neural
crest migration visualized by whole mount in situ hybridization for Twist expression. Krox20 is used to visualize rhombomeres 3/5 in the hindbrain.
Untreated n=8; Co(III)-EboxMut n=8; and Co(III)-Ebox n=12. (B) Quantification of mandibular, hyoid and branchial streams of neural crest cells are
represented as the distance migrated as a percentage of control embryos. T-tests determined that neither Co(III)-EboxMut nor Co(III)-Ebox had a
significant effect on neural crest cell migration. (C) Sibling embryos were maintained until swimming tadpole stages at 14 uC (top panel) or 27 uC
(bottom panel) when melanocyte formation could be assessed. Arrowheads point to regions of diminished melanocytes. For embryos maintained at
14uC, untreated n=12; Co(III)-EboxMut n=12; and Co(III)-Ebox n=12. For embryos maintained at 27uC, untreated n=12; Co(III)-EboxMut n=12; and
Co(III)-Ebox n=13. (D) Same embryos were maintained until swimming tadpole stages at 14 uC (top panel) or 27 uC (bottom panel) when craniofacial
cartilage formation could be assessed. Cartliage was stained with Alcian blue and dissected to visualize cartilage formation. (E) Injected embryos were
reared at 14 uC (top panel) or 27 uC (bottom panel) until stage 28 and glial cell formation was visualized by whole mount in situ hybridization for
FoxD3 expression. For embryos maintained at 14uC, untreated n=15; Co(III)-EboxMut n=17; and Co(III)-Ebox n=11. For embryos maintained at 27uC,
untreated n=15; Co(III)-EboxMut n=15; and Co(III)-Ebox n=22. (F) Injected embryos were reared at 14 uC (top panel) or 27 uC (bottom panel) until
stage 28 and primary neuron formation was visualized by whole mount in situ hybridization for N-tubulin expression. For embryos maintained at
14uC, untreated n=15; Co(III)-EboxMut n=17; and Co(III)-Ebox n=13. For embryos maintained at 27uC, untreated n=20; Co(III)-EboxMut n=21; and
Co(III)-Ebox n=21.
doi:10.1371/journal.pone.0032318.g005
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binding proteins such as bHLH transcription factors.
In contrast to RNAi approaches, Co(III)-Ebox-mediated
inhibition of Snai1 blocks Snai1 activity without affecting Snai1
protein levels. Co(III)-DNA conjugates therefore represent a novel
approach for specifically blocking the function of targets in vitro
and in vivo, without the requirement for decreasing the expression
level of the protein itself. While in the present report we utilize this
approach to block Snail protein function in tumor derived cells
and early embryos, this methodology should prove applicable to
targeted regulation of transcriptional events by a broad range of
potential protein targets.
To demonstrate the utility of the Co(III)-Ebox conjugate, we
have used it to probe the temporal requirements for Snail family
function during neural crest development in Xenopus. We have
used two approaches to controlling the timing of Co(III)-Ebox-
mediated Snail inhibition in early embryos. Control over the time
of application is a major advantage that chemical inhibitors hold
over genetic means of inhibiting protein activity. Reagents such as
RNAi affect the translation of new proteins but do nothing to
inhibit protein already expressed within a cell, which must turn
over before functional effects will be observed. Moreover, the
temperature dependence of Co(III)-Ebox function affords an
additional level of control that will prove of great value in model
organism-based studies. As a consequence the Co(III)-DNA
conjugate can be introduced into cells or tissues at one time but
kept at a temperature where it is largely inactive. Because the
reagent remains stable in the cytoplasm for long periods of time,
Co(III)-Ebox-mediated inhibition can subsequently be activated by
shifting to a higher temperature (Figure 6).
In this study we demonstrate the power that this level of control
affords. We first demonstrate the specificity and temporal control
of Co(III)-Ebox by showing that this means of inhibiting Snail
function phenocopies the effects of molecular genetic approaches
for inhibiting Snail function, while limiting off-target effects
[1,7,9,40]. Co(III)-Ebox effectively blocks the formation of the
neural crest precursor cells and the subsequent migration of these
cells, while not impairing the formation of the CNS or mesoderm.
Indeed, the current experiments shed further light on the temporal
requirements for Snail function at premigratory neural crest
stages. These experiments indicate that once neural crest
precursors have formed, Snail function is not required for the
maintenance of these precursors, as indicated by the continued
expression of neural crest markers even in the presence of Co(III)-
Ebox. The next functional consequence of Co(III)-Ebox-mediated
Snail inhibition was the failure of proper neural crest migration.
To examine if there were further requirements for Snail function,
such as during neural crest cell fate diversification, we activated
Co(III)-Ebox only after neural crest migration was well underway.
In this way we found that Snail function was required for the
normal formation of at least one neural crest derivative,
melanocytes, whereas neural crest derived cartilage and cranial
neurons and glia developed normally despite inhibition of Snail
function.
Snail repressors are known to directly or indirectly regulate the
expression of other transcription factors in the complex gene
regulatory network that controls neural crest formation and
differentiation. In Xenopus, Snai1 is known to positively affect Sox10
expression during the formation of neural crest precursor stem
cells, presumably indirectly [41]. This is significant given that at
later stages of development Sox10 has been shown to play an
essential role in the formation of the pigment cell lineage including
melanocytes [42]. Although a role for Snail-dependent regulation
of Sox10 at these stages has not been previously reported, it is
possible that inhibition of melanocyte formation by Co(III)-Ebox
could result from the down-regulation of Sox10 following inhibition
of Snail function. FoxD3 also plays roles in pigment cell and glia
formation [43] and is positively regulated by Snail, however, we
found that FoxD3 expression in glial cells was unperturbed at stage
28 in treated embryos. Moreover, given that Sox10 has been shown
to promote both melanocyte and glial cell formation while
inhibiting neuron formation [44], the normal development of glia
and neurons in treated embryos suggests that Sox10 function is not
lost in all lineages. Further examination of the temporal
requirements of Snail function, and its impact on the expression
of other neural crest regulatory factors, should lead to a fuller
understanding of the role of Snail in melanocyte formation as well
as other neural crest cell derivatives.
Our findings on the effects of Co(III)-Ebox-mediated Snail
inhibition in neural crest cells have implications beyond the
development of this important cell type. Previous studies have
reported the utility of Co(III) Schiff base complexes as targeted
protein inhibitors in vitro [27,28,29,30]. Moreover, non-targeted
Co(III) Schiff base complexes have demonstrated some efficacy as
viral inhibitors following topical application. [45,46,47]. Our
findings on the inhibition of transcription factors in tumor-derived
cells, and in neural crest stem cells, are the first report of a Co(III)
Schiff base complex functioning as an intracellular and even
Figure 6. Proposed model for the temperature-dependent inactivation of proteins targeted by Co(III)-Ebox.
doi:10.1371/journal.pone.0032318.g006
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studies, and as such represent a significant advancement in the
field.
Our results further demonstrate the power and potential of
Co(III)-DNA conjugates for the study of developmental events
regulated by zinc finger transcription factors, and highlight the
exceptional temporal control afforded by these agents. Generation
of Co(III) Schiff base complexes targeted to other zinc finger
transcription factors should prove a broadly applicable strategy for
targeted inhibition of factors that play key roles in other
developmental and disease processes. The flexible nature of such
DNA-conjugated Co(III) Schiff base complexes permits more
facile development of inhibitors compared to conventional small
molecule drugs, since novel inhibitors can be rationally designed
simply by changing the targeting sequence. In the case of Co(III)-
Ebox, our findings suggest that this conjugate holds significant
therapeutic promise as an inhibitor of Snail-dependent tumor
progression and recurrence. We further show that this agent can
be used in model organisms to shed important light on the
function of this important family of transcriptional regulatory
proteins.
Materials and Methods
Plasmids and Snai1 shRNA
Luciferase reporter gene constructs containing wild-type E-
cadherin promoter sequences were a gift from E. Fearon [35]. The
E-cadherin promoter region containing 3 Eboxes, from 2108 to
+125 of the endogenous E-cadherin gene, was cloned into pGL2-
Basic upstream of firefly Luciferase (Ecad-luc). Ebox elements in
the E-cadherin promoter in Ecad-luc were mutated from 59-
CAGGTG-39 to 59AAGGTA-39 in EcadMut-luc. Murine Snail
(MSnail) cDNA was cloned into a pCS2 variant that adds 5 myc
tags to the N- terminus as has been previously described [30]. A
short hairpin RNA (shRNA) targeting Snail in pLKO was obtained
from Sigma Aldrich (St. Louis, MO).
Reporter gene assays
Cell lines were transfected using ExGen500 (Fermentas)
according to manufacturer’s protocol. In experiments examining
repression of the E-cadherin reporter gene construct by endogenous
Snail, 200 ng E-cadherin construct (Ecad-luc or EcadMut-luc),
50 ng of Renilla luciferase construct as a control and the indicated
amount of experimental compound [Ebox, Co(III)-sb, Co(III)-
EboxMut, or Co(III)-Ebox] were transfected per well. To
determine the effects of Co(III)-Ebox and other experimental
compounds on MSnail repression of the E-cadherin promoter,
20 ng of MSnail was transfected with 200 ng E-cadherin construct,
50 ng of Renilla luciferase construct as a control and the indicated
amount of experimental compound [Ebox, Co(III)-sb, Co(III)-
EboxMut, or Co(III)-Ebox]. In each experiment the total DNA
transfected in each well was equalized by the addition of non-
coding DNA as pCS2+ empty vector to samples that do not
contain experimental compound.
Cell extracts were prepared 24 h after transfection using Passive
lysis buffer (Promega Corp.) followed by determination of firefly
luciferase and Renilla luciferase activity using the Dual-Luciferase
Reporter assay kit (Promega Corp). Results were normalized by
dividing by Renilla activity and are reported as fold inductions.
Statistical analysis was performed on means using a t-test.
Electrophoretic mobility shift assay
Electrophoretic mobility shift assays for XSnai2 and XMitF
were performed as previously described [27]. Images presented are
a representative replicate of triplicate samples. Band intensities
were quantified on a STORM 680 PhosphorImager (GE
Healthcare, Piscataway, NJ). Slug-bound band intensity values
were normalized to the background signal in each individual lane
using ImageQuant 5.2. The percentage of residual complex bound
to Slug probe is the normalized intensity of each treatment divided
by the normalized intensity of the untreated lane. These values for
Co(III)-Ebox were averaged over three replicates and reported
with the standard error. Statistical analysis was performed on the
means using a t-test.
Co(III)-Ebox stability in embryo lysates
Untreated X. laevis embryos were collected and lysed at the
blastula stage. Co(III)-Ebox (0.1 mM) was incubated at room
temperature in embryo lysate for 0, 1, 2, 4, 8, 12 and 24 hours. At
each of the indicated times an aliquot of Co(III)-Ebox in embryo
lysate was removed and frozen at 280 uC. Once all of the
timepoints had been collected and frozen X. laevis Snai2 (Slug)
protein in vitro translated from plasmid DNA using the TNTH
Reticulocyte lysate system (Promega Corp.) was added to each
sample along with EMSA binding buffer and
32P-labeled Slug
probe, and samples were separated by electrophoretic mobility
shift assay as previously described [27].
Western Blot Analysis
For Western blots, cell lysates from EMSA were used. Samples
were denatured and resolved on SDS/PAGE. Proteins were
detected using polyclonal Snail1-specific rabbit polyclonal anti-
body was obtained from Abcam (Cambridge, MA) and polyclonal
Actin-specific rabbit antibody was obtained from Sigma-Aldrich
(St. Louis, MO). Immunoreactive bands were detected using an
enhanced chemiluminescence solution (SuperSignal West Pico
Chemiluminescent Substrate; Pierce, Rockford, IL). Band images
were obtained by using ChemiDoc XRS+ (Bio-Rad, Hercules,
CA) and band intensity analyzed by Image Lab
TM software
version 2.0.1 (Bio-Rad, Hercules, CA). Images presented are a
representative replicate of triplicate samples. Snai1 band intensity
values were normalized to the Actin signal in each individual lane.
The percentage of residual Snai1 expressed is the normalized
intensity of each treatment divided by the normalized intensity of
the untreated lane. These values for were averaged over three
replicates and reported with the standard error. Statistical analysis
was performed on the means using a t-test.
Embryo preparation and methods
Pigmented and albino eggs from Xenopus laevis were obtained
and fertilized using standard protocols [48]. All embryos are
staged using the Niewkoop-Faber method. Embryos were
microinjected into one cell at the 8-cell stage, the blastocoel at
stage 10 or the archenteron space at stage 13 using a
micromanipulator. Whole mount in situ hybridization was
performed with digoxigenin-labeled antisense RNA probes as
previously described [49].
The distance of neural crest cell migration was measured in
ImageJ 1.42I. The length of each embryo head was measured
from the dorsal midline to the ventral side directly behind the eye
cup. Each of the streams of neural crest cell migration was
measured independently. The relative percentage of distance
migrated of the neural crest of Co(III)-Ebox or Co(III)-EboxMut
treated embryos was calculated by comparing the distance
migrated of treated embryos to the distance migrated of untreated
embryos.
For cartilage staining, embryos were fixed in formaldehyde at
stages 40–43 and stained overnight in 0.2% alcian blue/30%
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series into 80% glycerol/2% KOH before manual dissection of
cartilages.
All animal work was conducted according to relevant national
and international guidelines and was approved by Northwestern
University’s Animal Care and Use Committee (approved protocol
number 2010–0125, Animal Assurance Number A3283-01).
Supporting Information
Figure S1 Breast cancer cell lines express different
levels of Snai1 protein. Western Blot of Snai1 and Actin
protein in a panel of breast cancer cell lines.
(TIF)
Figure S2 Exogenous MSnail represses E-cadherin re-
porter gene activity in MCF7 cells. E-cadherin reporter gene
activity in MCF7 cells transfected with empty vector (pCS2+)o r
MSnai1. Values are expressed as relative light units compared to
pCS2+ samples. Data are represented as means 6 s.e.m., n=4.
(TIFF)
Figure S3 Co(III)-Ebox represses XSnai2 DNA-binding
more effectively than Co(III)-EboxMut. Lysates of unin-
jected blastula stage embryos (lane 1) or embryos with overex-
pressed XSnai2 protein (lanes 2–8) were incubated with increasing
concentrations of Co(III)-Ebox (lanes 3–5) or Co(III)-EboxMut
(lanes 6–8) of 0.5, 1, and 2 mM for 15 min before challenge with a
32P-labeled Ebox containing Slug DNA probe for 30 min.
Samples were analyzed by EMSA on a native TBE/acrylamide
gel. Multiple shifted complexes were observed for XSnai2 as
previously reported [27,50]. Co(III)-Ebox inhibits all specific
complexes as seen in lanes 3–5 [27].
(TIF)
Figure S4 Co(III)-Ebox represses XSnai2 DNA binding
but does not affect XMitF DNA binding. (A) Lysates of
uninjected blastula stage embryos (lanes 1 and 4) or embryos with
overexpressed XSnai2 protein (lanes 2 and 3) or XMitF (lanes 5–
10) were incubated with increasing concentrations of Co(III)-Ebox
of 0, 5, 15, 50, 150 or 500 nM for 15 min before challenge with a
32P-labeled Ebox containing Slug DNA probe for 30 min.
Samples were analyzed by EMSA on a native TBE/acrylamide
gel. (B) Western Blot analysis of XSnai2 and XMitF protein
expression levels in embryo lysates using an antibody against Myc,
as both XSnai2 and XMitF contain a 66 Myc epitope tag.
Dilutions of mRNA were used to establish equalized protein levels
for EMSA. Lysates from embryos injected with a 1:200 dilution of
XMitF mRNA or 1:100 dilution of XSnai2 mRNA were used to
examine DNA binding. Shifted bands for binding of XSnai2 (as in
Figure S3), XMitF and a non-specific band for the MitF probe are
indicated.
(TIF)
Figure S5 Ebox-binding proteins including Snail factors
expressed in MDA-MB-231 cells repress E-cadherin
promoter activity. Luciferase reporter gene activity of Ecad-
luc and EcadMut-luc in MDA-MB-231 cells. The mutations in the
Eboxes in EcadMut-luc do not allow for Ebox protein binding and
effective transcriptional repression. Values are expressed as
relative light units compared to Ecad-luc samples. Data are
represented as means 6 s.e.m., n=4.
(TIFF)
Figure S6 Snai1 protein expression level in MDA-MB-231 cells
after 24 h with 0 to 40 nM Co(III)-Ebox. Band intensities of
Western blots of Snai1 were obtained by using ChemiDoc XRS+
analyzed by Image Lab
TM software version 2.0.1. Snai1 band
intensity values were normalized to the Actin signal in each
individual lane. The percentage of residual Snai1 expressed is the
normalized intensity of each treatment divided by the normalized
intensity of the control. Data are represented as the means 6
s.e.m., n=3. Statistical analysis by t-test determined there was no
significant difference between any of the means.
(TIFF)
Figure S7 Co(III)-Ebox inhibits Snail-mediated neural crest cell
specification in Xenopus via a temperature-dependent mechanism.
Graphical representation of the percentage of embryos exhibiting
loss of neural crest cell formation as seen by in situ hybridization for
(A) FoxD3 or (B) Sox10 of control embryos or embryos injected with
Co(III)-sb, Ebox, Co(III)-EboxMut or Co(III)-Ebox and grown at
14uCo r2 7 uC.
(TIF)
Figure S8 Co(III)-Ebox impairs neural crest cell migration in
Xenopus embryos independently of neural crest specification.
Graphical representation of the percentage of embryos exhibiting
loss of neural crest cell formation as seen by in situ hybridization for
(A) FoxD3 or (B) Sox10 of control embryos or embryos injected with
Co(III)-sb, Ebox, Co(III)-EboxMut or Co(III)-Ebox and grown at
14uCo r2 7 uC.
(TIF)
Figure S9 Temperature modulation of Co(III)-Ebox-
mediated Snail inhibition reveals a requirement for
Snail in melanocyte formation. Graphical representation of
the percentage of embryos exhibiting loss of (A) melanocyte
formation, (B) cranial cartilage formation, (C) glial cell formation
(as seen by in situ hybridization for FoxD3), and (D) neuron
formation as seen by in situ hybridization for N-tubulitn of control
embryos or embryos injected with Co(III)-EboxMut or Co(III)-
Ebox and grown at 14uCo r2 7 uC.
(TIF)
Acknowledgments
The authors thank C Karras for aid with embryology experiments and J
Nguyen, M Heffern and T Atesin for technical support.
Author Contributions
Conceived and designed the experiments: ASH TJM CL. Performed the
experiments: ASH. Analyzed the data: ASH CL. Contributed reagents/
materials/analysis tools: ASH TJM CL. Wrote the paper: ASH CL.
References
1. Nieto MA, Sargent MG, Wilkinson DG, Cooke J (1994) Control of cell behavior
during vertebrate development by Slug, a zinc finger gene. Science 264: 835–839.
2. Chandler HL, Colitz CM, Lu P, Saville WJ, Kusewitt DF (2007) The role of the
slug transcription factor in cell migration during corneal re-epithelialization in
the dog. Exp Eye Res 84: 400–411.
3. Carver EA, Jiang R, Lan Y, Oram KF, Gridley T (2001) The Mouse Snail Gene
Encodes a Key Regulator of the Epithelial-Mesenchymal Transition. Mol Cell
Biol 21: 8184–8188.
4. LaBonne C, Bronner-Fraser M (1998) Induction and patterning of the neural
crest, a stem cell-like precursor population. J Neurobiol 36: 175–189.
5. Kouros-Mehr H, Werb Z (2006) Candidate regulators of mammary branching
morphogenesis identified by genome-wide transcript analysis. Dev Dyn 235:
3404–3412.
6. Hemavathy K, Hu X, Ashraf SI, Small SJ, Ip YT (2004) The repressor function
of Snail is required for Drosophila gastrulation and is not replaceable by
Escargot or Worniu. Developmental Biology 269: 411–420.
Inactivation of Core EMT Factors by Co(III)-Ebox
PLoS ONE | www.plosone.org 12 February 2012 | Volume 7 | Issue 2 | e323187. LaBonne C, Bronner-Fraser M (2000) Snail-related transcriptional repressors
are required in Xenopus for both the induction of the neural crest and its
subsequent migration. Dev Biol 221: 195–205.
8. Murray SA, Oram KF, Gridley T (2007) Multiple functions of Snail family genes
during palate development in mice. Development 134: 1789–1797.
9. Carl TF, Dufton C, Hanken J, Klymkowsky MW (1999) Inhibition of neural
crest migration in Xenopus using antisense slug RNA. Dev Biol 213: 101–115.
10. Vernon AE, LaBonne C (2004) Tumor metastasis: a new twist on epithelial-
mesenchymal transitions. Curr Biol 14: R719–721.
11. Foubert E, De Craene B, Berx G (2010) Key signalling nodes in mammary gland
development and cancer. The Snail1-Twist1 conspiracy in malignant breast
cancer progression. Breast Cancer Research 12: 206.
12. Kuphal S, Palm HG, Poser I, Bosserhoff AK (2005) Snail-regulated genes in
malignant melanoma. Melanoma Res 15: 305–313.
13. Vandewalle C, Comijn J, De Craene B, Vermassen P, Bruyneel E, et al. (2005)
SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell
junctions. Nucleic Acids Res 33: 6566–6578.
14. Castro Alves C, Rosivatz E, Schott C, Hollweck R, Becker I, et al. (2007) Slug is
overexpressed in gastric carcinomas and may act synergistically with SIP1 and
Snail in the down-regulation of E-cadherin. J Pathol 211: 507–515.
15. Emadi Baygi M, Soheili Z-S, Essmann F, Deezagi A, Engers R, et al. (2010)
Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate
cancer cell lines. Tumor Biology 31: 297–307.
16. Elloul S, Elstrand MB, Nesland JM, Trope CG, Kvalheim G, et al. (2005) Snail,
Slug, and Smad-interacting protein 1 as novel parameters of disease
aggressiveness in metastatic ovarian and breast carcinoma. Cancer 103:
1631–1643.
17. Martin TA, Goyal A, Watkins G, Jiang WG (2005) Expression of the
transcription factors snail, slug, and twist and their clinical significance in
human breast cancer. Ann Surg Oncol 12: 488–496.
18. DiMeo T, Anderson K, Phadke P, Fan C, Perou C, et al. (2009) A novel lung
metastasis signature links Wnt signaling with cancer cell self-renewal and
epithelial-mesenchymal transition in basal-like breast cancer. Cancer Res 69:
5364–5373.
19. Mani S, Guo W, Liao M, Eaton E, Ayyanan A, et al. (2008) The epithelial-
mesenchymal transition generates cells with properties of stem cells. Cell 133:
704–715.
20. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, et al. (2004) Snail blocks
the cell cycle and confers resistance to cell death. Genes Dev 18: 1131–1143.
21. Wu W, Heinrichs S, Xu D, Garrison S, Zambetti G, et al. (2005) Slug
antagonizes p53-mediated apoptosis of hematopoietic progenitors by repressing
puma. Cell 123: 641–653.
22. Goswami S, Philippar U, Sun D, Patsialou A, Avraham J, et al. (2009)
Identification of invasion specific splice variants of the cytoskeletal protein Mena
present in mammary tumor cells during invasion in vivo. Clin Exp Metastasis
26: 153–159.
23. Blanco MJ, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, et al. (2002)
Correlation of Snail expression with histological grade and lymph node status in
breast carcinomas. Oncogene 21: 3241–3246.
24. Geradts J, de Herreros AG, Su Z, Burchette J, Broadwater G, et al. (2011)
Nuclear Snail1 and nuclear ZEB1 protein expression in invasive and intraductal
human breast carcinomas. Human Pathology In Press, Corrected Proof.
25. Fillmore CM, Kuperwasser C (2008) Human breast cancer cell lines contain
stem-like cells that self-renew, give rise to phenotypically diverse progeny and
survive chemotherapy. Breast Cancer Res 10: R25.
26. Hwang W-L, Yang M-H, Tsai M-L, Lan H-Y, Su S-H, et al. (2011) SNAIL
Regulates Interleukin-8 Expression, Stem Cell-Like Activity, and Tumorigenic-
ity of Human Colorectal Carcinoma Cells. Gastroenterology 141:
279–291.e275.
27. Harney AS, Lee J, Manus LM, Wang P, Ballweg DM, et al. (2009) Targeted
inhibition of Snail family zinc finger transcription factors by oligonucleotide-
Co(III) Schiff base conjugate. Proceedings of the National Academy of Sciences
106: 13667–13672.
28. Louie AY, Meade TJ (1998) A cobalt complex that selectively disrupts the
structure and function of zinc fingers. Proc Natl Acad Sci U S A 95: 6663–6668.
29. Takeuchi T, Bottcher A, Quezada CM, Meade TJ, Gray HB (1999) Inhibition
of thermolysin and human alpha-thrombin by cobalt(III) Schiff base complexes.
Bioorg Med Chem 7: 815–819.
30. Takeuchi T, Bottcher A, Quezada CM, Simon MI, Meade TJ, et al. (1998)
Selective Inhibition of Human a-Thrombin by Cobalt(III) Schiff Base
Complexes. Journal of the American Chemical Society 120: 8555–8556.
31. Yang Z, Rayala S, Nguyen D, Vadlamudi RK, Chen S, et al. (2005) Pak1
phosphorylation of snail, a master regulator of epithelial-to-mesenchyme
transition, modulates snail’s subcellular localization and functions. Cancer Res
65: 3179–3184.
32. Olmeda D, Moreno-Bueno G, Flores JM, Fabra A, Portillo F, et al. (2007)
SNAI1 is required for tumor growth and lymph node metastasis of human breast
carcinoma MDA-MB-231 cells. Cancer Res 67: 11721–11731.
33. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, et al. (2007) The
transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by
repressing master regulators of epithelial polarity. Oncogene 26: 6979–6988.
34. Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, et al. (2001)
The two-handed E box binding zinc finger protein SIP1 downregulates E-
cadherin and induces invasion. Mol Cell 7: 1267–1278.
35. Hajra KM, Chen DY, Fearon ER (2002) The SLUG zinc-finger protein
represses E-cadherin in breast cancer. Cancer Res 62: 1613–1618.
36. Gupta PB, Kuperwasser C, Brunet JP, Ramaswamy S, Kuo WL, et al. (2005)
The melanocyte differentiation program predisposes to metastasis after
neoplastic transformation. Nat Genet 37: 1047–1054.
37. Tucker RP (2004) Neural crest cells: a model for invasive behavior. The
International Journal of Biochemistry & Cell Biology 36: 173–177.
38. de Herreros A, Peiro ´ S, Nassour M, Savagner P (2010) Snail Family Regulation
and Epithelial Mesenchymal Transitions in Breast Cancer Progression. Journal
of Mammary Gland Biology and Neoplasia 15: 135–147.
39. Le Douarin NM, Creuzet S, Couly G, Dupin E (2004) Neural crest cell plasticity
and its limits. Development 131: 4637–4650.
40. Aybar MJ, Nieto MA, Mayor R (2003) Snail precedes slug in the genetic cascade
required for the specification and migration of the Xenopus neural crest.
Development 130: 483–494.
41. Honore SM, Aybar MJ, Mayor R (2003) Sox10 is required for the early
development of the prospective neural crest in Xenopus embryos. Dev Biol 260:
79–96.
42. Aoki Y, Saint-Germain N, Gyda M, Magner-Fink E, Lee YH, et al. (2003)
Sox10 regulates the development of neural crest-derived melanocytes in Xenopus.
Dev Biol 259: 13–33.
43. Thomas AJ, Erickson C (2009) FOXD3 regulates the lineage switch between
neural crest-derived glial cells and pigment cells by repressing MITF through a
non-canonical mechanism. Development 136: 1849–1858.
44. Taylor KM, LaBonne CB (2005) SoxE Factors Function Equivalently during
Neural Crest and Inner Ear Development and Their Activity Is Regulated by
SUMOylation. Dev Cell 9: 593–603.
45. Epstein SP, Pashinsky YY, Gershon D, Winicov I, Srivilasa C, et al. (2006)
Efficacy of topical cobalt chelate CTC-96 against adenovirus in a cell culture
model and against adenovirus keratoconjunctivitis in a rabbit model. BMC
Ophthalmol 6: 22.
46. Asbell PA, Epstein SP, Wallace JA, Epstein D, Stewart CC, et al. (1998) Efficacy
of cobalt chelates in the rabbit eye model for epithelial herpetic keratitis. Cornea
17(5): 550–557.
47. Schwartz JA, Lium EK, Silverstein SJ (2001) Herpes simplex virus type 1 entry is
inhibited by the cobalt chelate complex CTC-96. J Virol 75(9): 4117–4128.
48. Bellmeyer A, Krase J, Lindgren J, LaBonne C (2003) The protooncogene c-myc
is an essential regulator of neural crest formation in xenopus. Dev Cell 4:
827–839.
49. LaBonne C, Bronner-Fraser M (1998) Neural crest induction in Xenopus:
evidence for a two-signal model. Development 125: 2403–2414.
50. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, et al. (2003) The
transcription factor Slug represses E-cadherin expression and induces epithelial
to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell
Sci 116: 499–511.
Inactivation of Core EMT Factors by Co(III)-Ebox
PLoS ONE | www.plosone.org 13 February 2012 | Volume 7 | Issue 2 | e32318